Repligen Corporation (FRA:RGN)

Market Cap	8.00B
Revenue (ttm)	603.33M
Net Income (ttm)	1.48M
Shares Out	n/a
EPS (ttm)	0.02
PE Ratio	5,401.43
Forward PE	86.39
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	34
Open	140.70
Previous Close	141.55
Day's Range	140.70 - 140.70
52-Week Range	94.12 - 170.00
Beta	n/a
RSI	58.50
Earnings Date	Feb 19, 2026

About Repligen

Repligen Corporation, a life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company also provides chromatography products, including OPUS pre-packed chromatography columns, which are used in the purification of biologics; and OPUS smaller-scale columns that are used in the high throughput process...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 1981
• Employees: 1,778
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: RGN

Financial Performance

Financial numbers in USD